Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12213985
Oral cannabinoid formulations
granted -
US 12213964
Isoxazoline parasiticide formulations
granted -
US 12215108
Development of potential antidotes for arsenicals
granted -
US 12213941
Adapter for use in a planetary mixer
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12215135
PDL2 compounds
granted -
US 12214083
Pharmaceutical composition and administrations thereof
granted -
US 12214031
Mannheimia haemolytica vector
granted -
US 12215090
Agents and methods for treating dysproliferative diseases
granted -
US 12215162
BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof
granted -
US 12215316
Materials and methods for treatment of usher syndrome type 2A
granted -
US 12215169
Anti-complement C1s antibodies and uses thereof
granted -
US 12213951
Treatment of autism with cannabidiol
granted -
US 12215320
Compositions and methods for gene editing by targeting transferrin
granted -
US 12215343
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12215148
Antigen binding molecule formats
granted -
US 12215349
Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same
granted -
US 12215355
Stem cell derived islet differentiation
granted -
US 12213977
Methods and compositions for treating melanoma
granted -
US 12219327
Substituted isoindolines as PI3K-alpha inhibitors
granted -
US 12215105
HPK1 antagonists and uses thereof
granted -
WO 2025023851
ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE MORPHOLINE
granted -
WO 2025023852
ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE MORPHOLINE
granted -
US 2025034157
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.